@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-KW26S3M1-N skos:prefLabel "Anxiolytiques"@fr, "Anti-Anxiety Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-CQ2KMNMH-W skos:prefLabel "Piperidines"@en, "Pipéridines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZK19LZH7-K . jvr:-PXB4GFQL-Z skos:prefLabel "Serotonin Antagonists"@en, "Antisérotonines"@fr ; a mesh:Descriptor, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-ZK19LZH7-K skos:hiddenLabel "R55667"@fr, "Tartrate de ritansérine"@fr, "Chlorhydrate de ritansérine"@fr, "R-55667"@fr, "R-55667"@en, "Ritanserin Hydrochloride"@en, "Ritanserin Tartrate"@en ; mesh:pharmacologicalAction jvr:-FRV1PNZN-9, jvr:-X5BRM0BB-H, jvr:-KW26S3M1-N, jvr:-PXB4GFQL-Z ; skos:altLabel "87051-43-2 (Ritanserin)"@en, "87051-43-2 (Ritanserin)"@fr, "6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one"@en, "98185-19-4 (HCl)"@fr, "98185-19-4 (HCl)"@en, "93076-39-2 (tartrate)"@fr, "93076-39-2 (tartrate)"@en, "145TFV465S"@fr, "145TFV465S"@en, "5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-"@fr, "5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-"@en ; mesh:allowableQualifier jvr:-CB30NGKB-3, jvr:-NB0XHT3S-N, jvr:-R3QWLHRG-V, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-L6C0XPHT-4, jvr:-R0ZCQ8X6-J, jvr:-M63HSDM7-1, jvr:-G30ZJ446-J, jvr:-SBNWSM1T-R, jvr:-BT300B3G-Q, jvr:-G4R176S9-J, jvr:-XV06LPML-W, jvr:-HQRFT0C6-B, jvr:-W6SQV79N-S, jvr:-D0F21513-5, jvr:-NKM836P1-M, jvr:-WK5F724J-1, jvr:-TJHVZCRZ-0, jvr:-T9HQD7ST-J, jvr:-THHNVC7V-3, jvr:-FWD2BGQ0-9, jvr:-Q3979798-W ; skos:inScheme jvr: ; skos:prefLabel "Ritanserin"@en, "Ritansérine"@fr ; skos:definition "A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure."@en ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-CQ2KMNMH-W, jvr:-DQJTSXCN-9 ; dc:established "1992-01-01"^^xsd:date ; dc:modified "2016-05-31"^^xsd:date ; owl:sameAs ; dc:created "1991-02-11"^^xsd:date . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-X5BRM0BB-H skos:prefLabel "Antidépresseurs de seconde génération"@fr, "Antidepressive Agents, Second-Generation"@en ; a mesh:Descriptor, skos:Concept . jvr:-DQJTSXCN-9 skos:prefLabel "Pyrimidinones"@fr, "Pyrimidinones"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZK19LZH7-K . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FRV1PNZN-9 skos:prefLabel "Antipsychotic Agents"@en, "Neuroleptiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .